Accession 447
Title Pilot phase I/II personalized therapy trial for metastatic colorectal cancer: evaluating the feasibility of protein pathway activation mapping for stratifying patients to therapy with imatinib and panitumumab
Summary This nonrandomized phase I/II trial assessed the efficacy/tolerability of imatinib plus panitumumab in patients affected by metastatic colorectal cancer (mCRC) after stratification to treatment by selection of activated imatinib drug targets using reverse-phase protein array (RPPA).
Journal J Proteome Res.
Publish date May, 2014
Corresponding Author E. Petricoin
Array Type Reverse phase protein array
Species Homo sapiens
Raw data link No relevant experiment link!
Link to PubMed

PubMed ID:24787230